Heron Therapeutics reported $82.91M in Operating Expenses for its second fiscal quarter of 2021.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Operating Expenses Change
Adamas Pharmaceuticals ADMS:US 31.13M 2.29M
Alexion Pharmaceuticals ALXN:US $ 1000.3M 30.6M
ALKERMES ALKS:US 299.3M 29.33M
Alnylam Pharmaceuticals ALNY:US $ 366.71M 2.89M
Amarin AMRN:US 145.72M 2.21M
Ani Pharmaceuticals ANIP:US $ 64.18M 12.7M
Anika Therapeutics ANIK:US $ 28.96M 4.07M
Arrowhead Research ARWR:US $ 77.76M 16.72M
Eisai 4523:JP Y 143487M 10048M
Emergent Biosolutions EBS:US $ 383M 135.4M
Endo International Ordinary Shares ENDP:US $ 570.72M 35.49M
Esperion Therapeutics ESPR:US $ 73.19M 17.61M
Flexion Therapeutics FLXN:US $ 45.06M 2.67M
GlaxoSmithKline GSK:LN 6.42B 692M
Gw Pharmaceuticals GWPH:US 173.49M 2.46M
Heron Therapeutics HRTX:US $ 82.91M 10.78M
Immunogen IMGN:US $ 44.32M 305K
Insmed INSM:US $ 151.62M 27.57M
JAZZ PHA JAZZ:US $ 821.4M 375.94M
Ligand Pharmaceuticals LGND:US $ 38.94M 16.3M
Merk MRK:US $ 9905M 839M
Nektar Therapeutics NKTR:US $ 138.54M 5.5M
Neurocrine Biosciences NBIX:US $ 226.1M 21M
Omeros OMER:US $ 52.84M 1.17M
Pacira Pharmaceuticals PCRX:US $ 100.75M 1.16M
Regeneron Pharmaceuticals REGN:US $ 1791.3M 375.3M
Sangamo Biosciences SGMO:US $ 76.57M 3.99M
Surmodics SRDX:US $ 26.26M 745K
Teva Pharmaceutical Industries TEVA:US 3.33B 220M
Ultragenyx Pharmaceutical RARE:US $ 169.75M 36.21M
Veracyte VCYT:US $ 62.58M 19.54M
Vertex Pharmaceuticals VRTX:US $ 1831.33M 994.85M
Zogenix ZGNX:US $ 74.22M 8.73M